|
GTPBP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.021330E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.884900E-03 |
| Normal-vs-Stage2 |
3.421700E-03 |
| Normal-vs-Stage3 |
3.974200E-04 |
| Normal-vs-Stage4 |
7.041500E-02 |
| Stage1-vs-Stage2 |
4.252400E-01 |
| Stage1-vs-Stage3 |
1.624770E-01 |
| Stage1-vs-Stage4 |
5.214000E-01 |
| Stage2-vs-Stage3 |
8.093000E-01 |
| Stage2-vs-Stage4 |
2.669000E-01 |
| Stage3-vs-Stage4 |
1.157220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.237000E-04 |
| Normal-vs-AfricanAmerican |
3.351200E-01 |
| Normal-vs-Asian |
6.224400E-01 |
| Caucasian-vs-AfricanAmerican |
1.086590E-01 |
| Caucasian-vs-Asian |
4.318000E-01 |
| AfricanAmerican-vs-Asian |
9.860000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36859999999117E-05 |
| Normal-vs-Female |
1.330440E-01 |
| Male-vs-Female |
1.202190E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.289020E-01 |
| Normal-vs-Age(41-60Yrs) |
9.623200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.458200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.071700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.115600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.799200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.575600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.176000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.433000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.987000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.570600E-01 |
| Normal-vs-Grade 2 |
9.802500E-03 |
| Normal-vs-Grade 3 |
2.34799999999646E-05 |
| Normal-vs-Grade 4 |
5.979800E-02 |
| Grade 1-vs-Grade 2 |
1.129200E-01 |
| Grade 1-vs-Grade 3 |
1.707670E-02 |
| Grade 1-vs-Grade 4 |
2.236200E-01 |
| Grade 2-vs-Grade 3 |
1.465750E-02 |
| Grade 2-vs-Grade 4 |
9.943200E-01 |
| Grade 3-vs-Grade 4 |
1.355370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.173640E-02 |
| Normal-vs-ccB subtype |
7.799300E-04 |
| ccA subtype-vs-ccB subtype |
8.869600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.008600E-04 |
| Normal-vs-N1 |
5.217800E-01 |
| N0-vs-N1 |
1.018210E-01 |
|
|
